Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(biphenyl-4-ylsulfonyl)-D-leucine is a synthetic small molecule and a derivative of the amino acid leucine, featuring a biphenyl ring system connected to a sulfonamide group. It acts as an inhibitor of macrophage metalloelastase, an enzyme involved in tissue remodeling and inflammation. This compound has been studied primarily as an experimental tool or discovery agent in medicinal chemistry and biochemistry for its potential to modulate inflammatory pathways and tissue repair mechanisms. There are no approved indications or clinical trials beyond preclinical research[1][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-(biphenyl-4-ylsulfonyl)-D-leucine.